| Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan International journal of pharmaceutics 544 (1), 285-296, 2018 | 143 | 2018 |
| Oral drug delivery systems using chemical conjugates or physical complexes TA Al-Hilal, F Alam, Y Byun Advanced drug delivery reviews 65 (6), 845-864, 2013 | 113 | 2013 |
| Functional transformations of bile acid transporters induced by high-affinity macromolecules TA Al-Hilal, SW Chung, F Alam, J Park, KE Lee, H Jeon, K Kim, IC Kwon, ... Scientific reports 4 (1), 4163, 2014 | 55 | 2014 |
| Oligomeric bile acid-mediated oral delivery of low molecular weight heparin TA Al-Hilal, J Park, F Alam, SW Chung, JW Park, K Kim, IC Kwon, IS Kim, ... Journal of controlled release 175, 17-24, 2014 | 55 | 2014 |
| Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid F Alam, TA Al-Hilal, SW Chung, D Seo, F Mahmud, HS Kim, SY Kim, ... Biomaterials 35 (24), 6543-6552, 2014 | 51 | 2014 |
| A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway JU Choi, SW Chung, TA Al-Hilal, F Alam, J Park, F Mahmud, JH Jeong, ... Biomaterials 139, 56-66, 2017 | 29 | 2017 |
| Targeting prion-like protein doppel selectively suppresses tumor angiogenesis TA Al-Hilal, SW Chung, JU Choi, F Alam, J Park, SW Kim, SY Kim, ... The Journal of clinical investigation 126 (4), 1251-1266, 2016 | 27 | 2016 |
| Self-assembled nanocomplex of PEGylated protamine and heparin–suramin conjugate for accumulation at the tumor site J Park, SR Hwang, JU Choi, F Alam, Y Byun International Journal of Pharmaceutics 535 (1-2), 38-46, 2018 | 19 | 2018 |
| Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate) F Alam, TA Al-Hilal, J Park, JU Choi, F Mahmud, JH Jeong, IS Kim, ... Biomaterials 86, 56-67, 2016 | 18 | 2016 |
| Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer F Mahmud, OC Jeon, F Alam, R Maharjan, JU Choi, J Park, S Lee, ... Journal of controlled release 284, 160-170, 2018 | 17 | 2018 |
| Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects TA Al-Hilal, MA Hossain, A Alobaida, F Alam, A Keshavarz, ... Journal of Controlled Release 334, 237-247, 2021 | 16 | 2021 |
| Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management F Mahmud, SW Chung, F Alam, JU Choi, SW Kim, IS Kim, SY Kim, DS Lee, ... Journal of Controlled Release 249, 42-52, 2017 | 15 | 2017 |
| Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy F Alam, TA Al-Hilal, SW Chung, J Park, F Mahmud, D Seo, HS Kim, ... Journal of controlled release 197, 180-189, 2015 | 15 | 2015 |
| Preliminary safety evaluation of a taurocholate‐conjugated low‐molecular‐weight heparin derivative (LHT7): a potent angiogenesis inhibitor F Alam, SW Chung, SR Hwang, J Kim, J Park, HT Moon, Y Byun Journal of Applied Toxicology 35 (1), 104-115, 2015 | 10 | 2015 |
| Prevention effect of orally active heparin conjugate on cancer-associated thrombosis TA Al-Hilal, F Alam, JW Park, K Kim, IC Kwon, GH Ryu, Y Byun Journal of controlled release 195, 155-161, 2014 | 10 | 2014 |
| Properties of heparinoids premixed with tumor-derived extracellular vesicles S Manandhar, J Park, VK Kothandan, J Lee, F Alam, JP Jee, J Hwang, ... Bioconjugate Chemistry 29 (11), 3757-3767, 2018 | 6 | 2018 |
| Safety studies on intravenous infusion of a potent angiogenesis inhibitor: taurocholate-conjugated low molecular weight heparin derivative LHT7 in preclinical models F Alam, SR Hwang, TA Al-Hilal, SW Chung, HS Kim, BH Kang, HS Zhang, ... Drug Development and Industrial Pharmacy 42 (8), 1247-1257, 2016 | 6 | 2016 |
| Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice J Kim, F Alam, SW Chung, J Park, OC Jeon, SY Kim, WC Son, Y Byun Anti-Cancer Drugs 25 (9), 1061-1071, 2014 | 6 | 2014 |
| Cytologically Indeterminate Follicular Thyroid Nodule on Fine Needle Aspiration Cytology is an Indication for Total Thyroidectomy. F Mahmud, AB Siddique, F Alam, MI Siddique Mymensingh Medical Journal: MMJ 28 (2), 434-440, 2019 | 5 | 2019 |
| Targeting angiogenic growth factors using therapeutic glycosaminoglycans on doppel-expressing endothelial cells for blocking angiogenic signaling in cancer JU Choi, X Zhang, MM Hasan, M Karim, SW Chung, F Alam, F Alqahtani, ... Biomaterials 283, 121423, 2022 | 3 | 2022 |
Taslim A. Al-HilalAssociate Professor, Departments of Molecular Pharmaceutics and BME, The University of UtahVerified email at pharm.utah.edu
